Korean J Fam Pract 2020; 10(2): 136-142  https://doi.org/10.21215/kjfp.2020.10.2.136
Prevalence and Predictors of Polypharmacy among Elderly Outpatients in a Public Hospital
Hyou Jung Koo, Min Ju Kim, Han Park, Jieun Chae, Junga Kim, Ki Hyun Park, Mooyoung Kim*
Department of Family medicine, Seoul Medical Center, Seoul, Korea
Mooyoung Kim
Tel: +82-2-2276-8605, Fax: +82-2-2276-7377
E-mail: moowija@seoulmc.or.kr
ORCID: http://orcid.org/0000-0002-3019-1632
Received: October 1, 2019; Revised: March 3, 2020; Accepted: March 11, 2020; Published online: April 20, 2020.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Polypharmacy, the use of multiple drugs, is a growing concern in older adults. It has been reported that the prevalence of polypharmacy in elderly patients is higher in Korea than in other countries. The objective of this study was to investigate the prevalence and associated factors of polypharmacy in elderly outpatients who visited a Seoul Medical Center.
Methods: We retrospectively reviewed medical records of 12,551 elderly patients aged ≥65 years who visited outpatient clinics in a public hospital in Seoul between January 1, 2018 and December 31, 2018. We defined “polypharmacy” as the use of ≥6 medications per person; “major polypharmacy,” ≥11 medications per person; and “excessive polypharmacy,” ≥21 medications per person. Multivariate logistic regression analysis was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to investigate the risk factors for polypharmacy.
Results: Among the elderly outpatients studied, 40.7% had polypharmacy, 11.9% major polypharmacy, and 0.8% excessive polypharmacy. The lowerincome medical aid population is associated with polypharmacy (OR, 1.70; 95% CI, 1.47–1.97).
Conclusion: We observed a high prevalence of polypharmacy in elderly outpatients, especially the medical aid population, who visited a Korean public hospital. Nationwide vigorous efforts to assess and reduce the prevalence of polypharmacy are urgently required for the Korean older population.
Keywords: Elderly; Polypharmacy; Public Hospital; Outpatient
  1. United Nations, Department of Economics and Social Affairs, Population Division. World population prospects 2019. New York (NY): United Nations;2019.
  2. Statistics Korea. Elderly statistics 2018 [Internet]. Daejeon: Statistics Korea;2018 [cited 2018 Sep 27].
  3. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163-84.
    Pubmed CrossRef
  4. Cheong SJ, Yoon JL, Choi SH, Kim MY, Cho JJ, Ju YS. The Effect of polypharmacy on mortality in the elderly. Korean J Fam Pract 2016; 6: 643-50.
  5. Fried TR, O'Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014; 62: 2261-72.
    Pubmed KoreaMed CrossRef
  6. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-51.
    Pubmed CrossRef
  7. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty:prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015; 24: 637-46.
    Pubmed CrossRef
  8. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 2014;77: 1073-82.
    Pubmed KoreaMed CrossRef
  9. Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 2011; 12: 1249-57.
    Pubmed CrossRef
  10. Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PLoS One 2014; 9: e98043.
    Pubmed KoreaMed CrossRef
  11. World Health Organization. A glossary of terms for community health care and services for older persons. Geneva: World Health Organization; 2004.
  12. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65: 989-95.
    Pubmed CrossRef
  13. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16.
    Pubmed KoreaMed CrossRef
  14. Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 2015; 5:e008656.
    Pubmed KoreaMed CrossRef
  15. Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf 2011; 20: 488-96.
    Pubmed CrossRef
  16. van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health 2011; 11: 101.
    Pubmed KoreaMed CrossRef
  17. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging 2010; 27: 1019-28.
    Pubmed CrossRef
  18. Kim AR. Assessment of polypharmacy and potentially inappropriate medication in elderly outpatients [dissertation]. Seoul: Ewha Womans Univ.;2015. Korean.
  19. Park BJ, Jung JH, Park KD, Soe SW, Kim SW. Study on diagnosis accuracy for health insurance claims data in Korea, report to Health Insurance Review and Assessment Services. Seoul: Medical School of Seoul National University; 2003. p. 17-29.

This Article